UberScientific is recalling about 76,000 units of Uber Numb Topical Anesthetic Cream and Uber Numb Spray (lidocaine) because the packaging is not child-resistant as required by law. The failure to use child-resistant closures means young children can easily access the products, which contain lidocaine. These products were sold online at Amazon.com and Uberscientific.com from February 2017 through April 2018. UberScientific is providing free child-resistant replacement caps for the cream and either a replacement cream with the new cap or a full refund for the spray.
The anesthetic products contain lidocaine, which poses a serious risk of poisoning to young children if they ingest the product or apply it to their skin. While no injuries have been reported, the lack of child-resistant packaging increases the danger of accidental exposure.
Consumers should immediately place the recalled topical anesthetic out of reach of children and contact UberScientific for instructions on how to receive a free replacement or full refund. Consumers with the recalled cream can receive a free replacement cap that is child-resistant. Consumers with the recalled spray can receive a free replacement cream with the new child-resistant cap or a full refund.
Recalled Uber Numb topical anesthetic cream
Recalled Uber Numb spray
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: CPSC Notice · Raw API Response